Cite
Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment.
MLA
Ahalwat, Shaveta, et al. “Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment.” Pharmaceuticals (Basel, Switzerland), vol. 16, no. 8, Aug. 2023. EBSCOhost, https://doi.org/10.3390/ph16081108.
APA
Ahalwat, S., Bhatt, D. C., Rohilla, S., Jogpal, V., Sharma, K., Virmani, T., Kumar, G., Alhalmi, A., Alqahtani, A. S., Noman, O. M., & Almoiliqy, M. (2023). Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment. Pharmaceuticals (Basel, Switzerland), 16(8). https://doi.org/10.3390/ph16081108
Chicago
Ahalwat, Shaveta, Dinesh Chandra Bhatt, Surbhi Rohilla, Vikas Jogpal, Kirti Sharma, Tarun Virmani, Girish Kumar, et al. 2023. “Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment.” Pharmaceuticals (Basel, Switzerland) 16 (8). doi:10.3390/ph16081108.